Clinical Trials Directory

Trials / Completed

CompletedNCT01452841

A Grapefruit Feeding Trial in Healthy, Overweight Adults

Efficiency of Daily Grapefruit Exposure in Reducing Body Weight and Inflammatory Markers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
85 (actual)
Sponsor
University of Arizona · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Folklore has suggested that consuming grapefruit may promote weight control. Sparse data exist to support this hypothesis, though there is some evidence of health promotional effects regarding blood pressure and lipid profiles. The aims of this randomized controlled trial are to determine the role of grapefruit in: 1. Reducing weight 2. Reducing blood pressure 3. Reducing inflammation 4. Improving the lipid profile. The investigators hypothesize that six weeks of daily consumption of grapefruit will reduce weight, blood pressure, and inflammation while improving the lipid profile in overweight, healthy adults.

Conditions

Interventions

TypeNameDescription
OTHERGrapefruit1.5 Rio Red Grapefruit consumed daily for 6 weeks
OTHERControlParticipants followed a diet low in bioactive rich fruits and vegetables and avoided citrus for six weeks

Timeline

Start date
2009-08-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2011-10-17
Last updated
2011-10-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01452841. Inclusion in this directory is not an endorsement.